Amphastar Pharmaceuticals, Inc. ( AMPH) - Stock Earnings
AMPH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 24.4 million USD | 183.1 million USD |
| 2026Q1 | 6.4 million USD | 171.2 million USD |
| 2026Q2 | 30.3 million USD | 183.9 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
AMPH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 137.5 million USD | 644.4 million USD |
| 2024 | 159.5 million USD | 732.0 million USD |
| 2025 | 98.1 million USD | 719.9 million USD |
| 2026 Est. | — | — |
AMPH
Price: $27.39
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.65 USD
P/E Ratio: 12.11
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 105125
Ebitda: 2.1 millionMarket Capitalization: 1.0 billion